SAB Biotherapeutics, Inc. (SABS) has 6 open-market insider trades by 5 insiders since 2021. The most active filer is Eddie Joe Sullivan, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Eddie Joe Sullivan | CEO | — | 2 | $12K | 2023-12-07 |
| Samuel J. Reich | Chairman | — | 1 | $10K | 2023-11-29 |
| Christine E. Hamilton | Dir10% Owner | — | 1 | $7K | 2022-12-07 |
| Michael King | CFO | — | 1 | $5K | 2023-11-30 |
| Russell P. Beyer | CFO | — | 1 | $2K | 2021-10-26 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Eddie Joe Sullivan | CEO | Buy | $2K | 2023-12-07 |
| Michael King | CFO | Buy | $5K | 2023-11-30 |
| Samuel J. Reich | Chairman | Buy | $10K | 2023-11-29 |
| Christine E. Hamilton | Director & 10% | Buy | $7K | 2022-09-13 |
| Eddie Joe Sullivan | CEO & 10% | Buy | $10K | 2022-09-07 |
| Russell P. Beyer | CFO | Sell | $2K | 2021-10-26 |
Companies that share insiders with SABS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.